Iron Metabolism and Red Blood Cell Disorders: Towards a Better Understanding of Rare Forms of Anemia

Thursday 26 November 2026, 10:30 am
Unraveling pathophysiological mechanisms in iron and red blood cell disorders
PhD candidate
V. Hoving
Promotor(s)
prof. dr. D.W. Swinkels, dr. S.E.M. Schols
Co-promotor(s)
dr. A.E. Donker
Location
Aula

This thesis advances the understanding of three rare inherited disorders that cause anemia: X-linked sideroblastic anemia (XLSA), iron-refractory iron deficiency anemia (IRIDA), and sickle cell disease. Research on XLSA showed that disturbed regulation of the hormone hepcidin likely contributes to iron overload and highlighted the large clinical differences between patients carrying the same genetic variant. In IRIDA, the findings demonstrated that a single TMPRSS6 variant is often insufficient to cause disease. Additional genetic factors appear to influence whether individuals develop anemia. The research also resulted in practical recommendations for a more personalized approach to IRIDA treatment. In sickle cell disease, several promising proteins in blood and urine were identified that are associated with early kidney damage. Together, these findings provide new insights into the mechanisms underlying anemia and iron dysregulation and establish a foundation for future advances in personalized diagnosis, prognosis, and treatment. 

Vera Hoving (Groningen, 1991) studied Medicine at the University of Groningen and obtained her medical degree in 2015. After two years of clinical experience as a resident physician (ANIOS), she started her residency in Internal Medicine at Radboud university medical center in 2018. During her training, she pursued a PhD in hematology, focusing on rare anemias and disorders of iron metabolism. Since 2025, she has continued her residency training with the ambition of specializing in hematology.